Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Virdee

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Scientific Reports|October 5, 2025
Channel quality predictions assisted by new algorithms for high throughput satellite and 5G systemsAli M Al-Saegh, Esraa Mousa Ali, Mariam Qutaiba Abdalrazak, et al.
Scientific Reports|May 11, 2026
A reconfigurable MTM-EMBG MIMO antenna array with solar panel integration for sustainable 5G networksSaif Al-Attar, Mohammad Alibakhshikenari, Yazeed Mohammad Qasaymeh, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Diagnostic and Prognostic Research|January 9, 2023
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataPradeep S Virdee, Clare Bankhead, Constantinos Koshiaris, et al.
The Lancet. Oncology|October 12, 2024
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysisAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
The Lancet. Oncology|June 23, 2023
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort studyBrian D Nicholson, Jason Oke, Pradeep S Virdee, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
Physical Review Letters|January 21, 2022
Search for Lepton-Flavor Violation in Z-Boson Decays with τ Leptons with the ATLAS DetectorG Aad, B Abbott, D C Abbott, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Scientific Reports|October 5, 2025
Channel quality predictions assisted by new algorithms for high throughput satellite and 5G systemsAli M Al-Saegh, Esraa Mousa Ali, Mariam Qutaiba Abdalrazak, et al.
Scientific Reports|May 11, 2026
A reconfigurable MTM-EMBG MIMO antenna array with solar panel integration for sustainable 5G networksSaif Al-Attar, Mohammad Alibakhshikenari, Yazeed Mohammad Qasaymeh, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Diagnostic and Prognostic Research|January 9, 2023
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataPradeep S Virdee, Clare Bankhead, Constantinos Koshiaris, et al.
The Lancet. Oncology|October 12, 2024
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysisAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
The Lancet. Oncology|June 23, 2023
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort studyBrian D Nicholson, Jason Oke, Pradeep S Virdee, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
Physical Review Letters|January 21, 2022
Search for Lepton-Flavor Violation in Z-Boson Decays with τ Leptons with the ATLAS DetectorG Aad, B Abbott, D C Abbott, et al.
Pageof 14